Duration of Humoral Immunity to Common Viral and Vaccine Antigens

Cited by (1,002)

Items 501–600 of 1,002

1. Tuning of plasma cell lifespan by competition explains the longevity and heterogeneity of antibody persistence
   Benjamin D. Simons, Omer Karin · 2024 · Immunity
2. Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
   Sumathy Velumani, Ying Xiu Toh, Shobana Balasingam, Sophia Archuleta, Yee‐Sin Leo, Victor Chih Hao Gan, Tun-Linn Thein, Annelies Wilder‐Smith, Katja Fink · 2016 · Human Vaccines & Immunotherapeutics
3. Molecular Basis for the Recognition of Herpes Simplex Virus Type 1 Infection by Human Natural Killer Cells
   Hongsheng Dai, Michael A. Caligiuri · 2018 · Frontiers in Immunology
4. The challenges of a circumsporozoite protein-based malaria vaccine
   Deepyan Chatterjee, Ian Andrew Cockburn · 2021 · Expert Review of Vaccines
5. Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates
   Nanda Kishore Routhu, Samuel David Stampfer, Lilin Lai, Akil Akhtar, Xin Tong, Dansu Yuan, Taras M. Chicz, Ryan P. McNamara, Kishor Jakkala, Meredith E. Davis-Gardner et al. · 2023 · Science Immunology
6. Mucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future Protection
   Joshua Tisdell Schiffer · 2013 · Frontiers in Immunology
7. Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials
   Pierre Van Damme, Peter Bruce McIntyre, E. Grimprel, Sherine O. Kuriyakose, Jeanne‐Marie Jacquet, Karin Hardt, Marc Messier, Olivier Van Der Meeren · 2011 · Vaccine
8. Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
   Saskia van der Lee, Debbie M. van Rooijen, Mary‐lène de Zeeuw‐Brouwer, Marjan Bogaard, Pieter G. M. van Gageldonk, Axel Bonačić Marinović, Elisabeth A. M. Sanders, Guy A. M. Berbers, Anne‐Marie Buisman · 2018 · Frontiers in Immunology
9. CD19-positive antibody-secreting cells provide immune memory
   C. J. Groves, Jeffrey A. Carrell, R. Grady, Bhargavi Rajan, Christopher A. Morehouse, Rebecca Halpin, J. Wang, Jincheng Wu, Yashaswi Shrestha, Radhika Rayanki et al. · 2018 · Blood Advances
10. Gambiense Human African Trypanosomiasis and Immunological Memory: Effect on Phenotypic Lymphocyte Profiles and Humoral Immunity
    Veerle Lejon, Dieudonné Mumba Ngoyi, Luc Kestens, Luc Boel, Barbara Barbé, Victor Kande Betu, Johan van Griensven, Emmanuel Bottieau, Jean‐Jacques Muyembe Tamfum, Jan Adriaan Jacobs et al. · 2014 · PLoS Pathogens
11. Temporal dynamics and genomic programming of plasma cell fates
    Godhev K. Manakkat Vijay, Ming Zhou, Kairavee Thakkar, Abigail Elizabeth Rothrauff, Amanpreet Singh Chawla, Dianyu Chen, Louis Lau, Peter Habib Gerges, Kashish Chetal, Prabal Chhibbar et al. · 2024 · Nature Immunology
12. Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers
    Kwinten Sliepen, Edith E. Schermer, Ilja Bontjer, Judith A. Burger, Réka Felfödiné Lévai, Philipp Mundsperger, Philip J. M. Brouwer, Monica Tolazzi, Attila Farsang, Dietmar Katinger et al. · 2021 · npj Vaccines
13. A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
    Phanramphoei Namprachan Frantz, Aleksandr Barinov, Claude Ruffié, Chantal Combredet, Valérie Najburg, Guilherme Dias de Melo, Florence Larrous, Lauriane Kergoat, Samaporn Teeravechyan, Anan Jongkaewwattana et al. · 2021 · Nature Communications
14. Dynamic organization of the bone marrow plasma cell niche
    Tonya Aaron, David Fooksman · 2022 · FEBS Journal
15. ‘Persistent germinal center responses: slow-growing trees bear the best fruits’
    Hanover C. Matz, Katherine M. McIntire, Ali H. Ellebedy · 2023 · Current Opinion in Immunology
16. Exploiting Human Memory B Cell Heterogeneity for Improved Vaccine Efficacy
    Noel T. Pauli, Carole Henry, Patrick C. Wilson · 2011 · Frontiers in Immunology
17. Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study
    Matthew James Bottomley, Mian Chen, Sue Fuggle, Paul Harden, Kathryn J. Wood · 2016 · Transplantation Direct
18. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection
    Susan L. Baldwin, Fan‐Chi Hsu, Neal Van Hoeven, Emily Gage, Brian Granger, Jeffrey A. Guderian, Sasha E. Larsen, Erica C. Lorenzo, Laura Haynes, Steven G. Reed et al. · 2018 · Frontiers in Immunology
19. Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials
    Michael T. White, Olubukola T. Idoko, Samba Ousmane Sow, Aldiouma Diallo, Beate Kampmann, Ray Borrow, Caroline L. Trotter · 2019 · The Lancet Infectious Diseases
20. An open source tool to infer epidemiological and immunological dynamics from serological data: serosolver
    James A. Hay, Amanda Minter, Kylie E. C. Ainslie, Justin Lessler, Bingyi Yang, Derek A. T. Cummings, Adam J. Kucharski, Steven Riley · 2020 · PLoS Computational Biology
21. Predicted Impact of Mass Drug Administration on the Development of Protective Immunity against Schistosoma haematobium
    Kate M. Mitchell, Francisca Mutapi, Takafira Mduluza, Nicholas Midzi, Nicholas Jon Savill, Mark E. J. Woolhouse · 2014 · PLoS neglected tropical diseases
22. Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals
    Jason Ho, Susan L. Moir, Wei Wang, Jacqueline G. Posada, Wenjuan Gu, Muhammad Tauseef Rehman, Robin J. Dewar, Colin C. Kovacs, Michael C. Sneller, Tae‐Wook Chun et al. · 2010 · AIDS
23. Myelin basic protein autoantibodies, white matter disease and stroke outcome
    Dean K. Shibata, Kevin C. Cain, Patricia M. Tanzi, Dannielle K. Zierath, Kyra J. Becker · 2012 · Journal of Neuroimmunology
24. Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients
    Mariam Movsisyan, Armine S. Chopikyan, Irina Kasparova, Gohar Hakobjanyan, Fabrice Carrat, Meline Sukiasyan, Marieta Rushanyan, Mariam Chalabyan, Sanobar Shariff, Burhan Kantawala et al. · 2022 · Scientific Reports
25. Making sense of plasma cell heterogeneity
    David Mathew Tarlinton, Zhoujie Ding, Julie Tellier, Stephen L. Nutt · 2023 · Current Opinion in Immunology
26. Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
    Katharina Röltgen, Scott Dexter Boyd · 2023 · Annual Review of Pathology Mechanisms of Disease
27. Waldenström Macroglobulinemia: Clinical and Immunological Aspects, Natural History, Cell of Origin, and Emerging Mouse Models
    Siegfried Janz · 2013 · ISRN Hematology
28. Intrathecal Humoral Immunity to Encephalitic RNA Viruses
    Timothy W. Phares, Stephen A. Stohlman, Cornelia C. Bergmann · 2013 · Viruses
29. External cues to drive B cell function towards immunotherapy
    Diana Stoycheva, Hasan Şimşek, Willi Weber, Anja Erika Hauser, Enrico Klotzsch · 2021 · Acta Biomaterialia
30. Regression of systemic lupus erythematosus after development of an acquired Toll‐like receptor signaling defect and antibody deficiency
    Marcella Visentini, Valentina Conti, Maria Cagliuso, Francesca Tinti, Giulia Siciliano, Amelia Chiara Trombetta, Anna Paola Mitterhofer, Massimo Fiorilli, Isabella Quinti · 2009 · Arthritis & Rheumatism
31. Antibody Responses in Hepatitis C Infection
    Mansun Law · 2020 · Cold Spring Harbor Perspectives in Medicine
32. Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands
    Joske Hoes, Anna G. C. Boef, Mirjam J. Knol, Hester E. de Melker, Liesbeth Mollema, Fiona R.M. van der Klis, Nynke Y. Rots, Debbie van Baarle · 2018 · Frontiers in Public Health
33. Sex and age as determinants of the seroprevalence of anti-measles IgG among European healthcare workers: A systematic review and meta-analysis
    Francesco Paolo Bianchi, Pasquale Stefanizzi, Paolo Trerotoli, Silvio Tafuri · 2022 · Vaccine
34. Assessing the impact of mRNA vaccination in chronic inflammatory murine model
    Seonghyun Lee, Jisun Lee, Sunhee Cho, Gahyun Roh, Hyo‐Jung Park, You-Jeung Lee, Ha-Eun Jeon, Yu‐Sun Lee, Seo‐Hyeon Bae, Sue Bean Youn et al. · 2024 · npj Vaccines
35. Optimization and validation of a high throughput method for detecting neutralizing antibodies against human papillomavirus (HPV) based on pseudovirons
    Jianhui Nie, Weijin Huang, Xueling Wu, Youchun Wang · 2014 · Journal of Medical Virology
36. Circulating B-Lymphocytes as Potential Biomarkers of Tuberculosis Infection Activity
    Ismail Sebina, Irene Andia Biraro, Hazel M. Dockrell, Alison M. Elliott, Stephen Cose · 2014 · PLoS ONE
37. Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines
    Robert E. Sealy, Richard J. Webby, Jeri Carol Crumpton, Julia L. Hurwitz · 2012 · International Immunology
38. Biology of Viruses and Viral Diseases
    James D. Chappell, Terence S. Dermody · 2015 · Elsevier eBooks
39. Maternal antibody and the maintenance of a lyssavirus in populations of seasonally breeding African bats
    David T. S. Hayman, Angela D. Luis, Olivier Restif, Kate S. Baker, Anthony R. Fooks, Clinton B. Leach, Daniel L. Horton, Richard Suu‐Ire, Andrew A. Cunningham, James L. N. Wood et al. · 2018 · PLoS ONE
40. Modeling Subacute Sclerosing Panencephalitis in a Transgenic Mouse System: Uncoding Pathogenesis of Disease and Illuminating Components of Immune Control
    Michael B. A. Oldstone · 2008 · Current topics in microbiology and immunology
41. Common community‐acquired infections and subsequent risk of multiple myeloma: A population‐based study
    Charlene M. McShane, Liam Murray, Eric A. Engels, Ola Landgren, Lesley Ann Anderson · 2013 · International Journal of Cancer
42. Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9
    Peter Allacher, Christina K. Baumgartner, Aniko Ginta Pordes, Rafi Uddin Ahmad, Hans Peter Schwarz, Birgit Maria Reipert · 2010 · Blood
43. Dynamics of measles immunity from birth and following vaccination
    Wei Wang, Megan O’Driscoll, Qianli Wang, Sihong Zhao, Henrik Salje, Hongjie Yu · 2024 · Nature Microbiology
44. HPV vaccination in head and neck HPV-related pathologies
    Małgorzata Wierzbicka, Agata Józefiak, Joanna Jackowska, Jarosław Szydlowski, Anna Goździcka‐Józefiak · 2014 · Otolaryngologia Polska
45. A community divided: Post‐transplant live vaccine practices among Society of Pediatric Liver Transplantation (SPLIT) centers
    Sarah Kemme, Shikha S. Sundaram, Donna J. Curtis, Steven Lobritto, Saeed Mohammad, Amy G. Feldman · 2020 · Pediatric Transplantation
46. Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
    Zijun Wang, Frauke Muecksch, Friederike Münn, Alice Cho, Shuai Zong, Raphael Raspe, Víctor Ramos, Brianna Johnson, Tarek Ben Tanfous, Justin DaSilva et al. · 2022 · The Journal of Experimental Medicine
47. Vaccine-Mediated Immunity Against Dengue and the Potential for Long-Term Protection Against Disease
    Mark K. Slifka · 2014 · Frontiers in Immunology
48. Detecting the Humoral Alloimmune Response
    Gonca E. Karahan, Frans H.J. Claas, Sebastiaan Heidt · 2015 · Transplantation
49. HLA‐specific memory B‐cell detection in kidney transplantation: Insights and future challenges
    Caroline Wehmeier, Gonca E. Karahan, Sebastiaan Heidt · 2020 · International Journal of Immunogenetics
50. Memory Generation and Re-Activation in Food Allergy
    Joshua F. E. Koenig, Kelly M. Bruton, Allyssa Phelps, Emily Grydziuszko, Rodrigo Jiménez‐Saiz, Manel Jordana · 2021 · ImmunoTargets and Therapy
51. Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19
    Alexander P. Underwood, Christina Søhoel Sølund, Carlota Fernandez-Antunez, Signe Lysemose Villadsen, Anni Assing Winckelmann, Signe Bollerup, Lotte S. Mikkelsen, Anna-Louise Sørensen, Shan Feng, Ulrik Fahnøe et al. · 2021 · EBioMedicine
52. Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination
    Julia Bitencourt, Marco Polo Peralta Álvarez, Morven Wilkie, Ashley Jacobs, Daniel Wright, Salem Salman Almujri, Shuailin Li, Stephanie A. Harris, Steven G. Smith, Sean C. Elias et al. · 2022 · Frontiers in Immunology
53. Recovery of an Antiviral Antibody Response following Attrition Caused by Unrelated Infection
    Dorothy Hui Lin Ng, John James Skehel, George Kassiotis, Jean Langhorne · 2014 · PLoS Pathogens
54. Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1
    Xian Li, Mengxin Xu, Jingyi Yang, Li Zhou, Lin Liu, Min Li, Shasha Wang, Meiqin Liu, Zhixiang Huang, Zhen Zhang et al. · 2024 · Signal Transduction and Targeted Therapy
55. Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms
    Andrea-Clemencia Pineda-Peña, Kohei Hasegawa, Vincent Pavot, Catherine Berry, Béhazine Combadière, Guadalupe Cortés-Garcia, Adrian B. McDermott, Saranya Sridhar · 2025 · npj Vaccines
56. Harnessing mucosal immunity for protective vaccines
    Dong-il Kwon, Sachin H. Bhagchandani, Stephen A. Ehrenzeller, Akiko Iwasaki · 2026 · Nature reviews. Immunology
57. Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA
    David S. Smookler, Aaron Vanderhoff, Mia J. Biondi, Jorge Alberto Sánchez Valencia, Pablo Ryan, Joel Karkada, Rachel Hong, Izza Sattar, Erin Mandel, Martina Gjevori et al. · 2020 · Clinical Gastroenterology and Hepatology
58. Determinants of IgG antibodies kinetics after severe and critical COVID‐19
    Julien De Greef, Anaïs Scohy, Francis Zech, Frank Aboubakar Nana, Charles Pilette, Ludovic Gérard, Lucie Pothen, Halil Yıldız, Leïla Belkhir, Jean Cyr Yombi · 2021 · Journal of Medical Virology
59. T Cell/B Cell Interactions in the Establishment of Protective Immunity
    Julia Ritzau-Jost, Andreas Hutloff · 2021 · Vaccines
60. Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses
    Shivana M. Lightman, Jennifer Peresie, Louise M. Carlson, G. Aaron Holling, Mackenzie M. Honikel, Colin A. Chavel, Michael J. Nemeth, Scott H. Olejniczak, Kelvin P. Lee · 2021 · Immunity
61. H3K27me3 Demethylase UTX Restrains Plasma Cell Formation
    Anna K. Kania, Madeline J. Price, Lou-Ella George-Alexander, Dillon G. Patterson, Sakeenah L. Hicks, Christopher D. Scharer, Jeremy M. Boss · 2022 · The Journal of Immunology
62. Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits
    Balasubramanian Arunachalam · 2024 · Vaccines
63. Impact of Acute Malaria on Pre-Existing Antibodies to Viral and Vaccine Antigens in Mice and Humans
    Simran Banga, Jill D. Coursen, Sílvia Portugal, Tuan M. Tran, Lisa S. Hancox, Aïssata Ongoïba, Boubacar Traoré, Ogobara K. Doumbo, Chiung‐Yu Huang, John T. Harty et al. · 2015 · PLoS ONE
64. Mechanisms of naturally acquired immunity toP. falciparumand approaches to identify merozoite antigen targets
    Julie Healer, Chris Y. H. Chiu, Diana S. Hansen · 2017 · Parasitology
65. Exhaustion may not be in the human B cell vocabulary, at least not in malaria
    Prasida Holla, Abhijit A. Ambegaonkar, Haewon Sohn, Susan K. Pierce · 2019 · Immunological Reviews
66. Pre-existing Alloreactive T and B Cells and Their Possible Relevance for Pre-transplant Risk Estimation in Kidney Transplant Recipients
    Gonca E. Karahan, Frans H.J. Claas, Sebastiaan Heidt · 2020 · Frontiers in Medicine
67. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens
    Guy A. M. Berbers, M.S.E. van de Wetering, Pieter G. M. van Gageldonk, Joop F. P. Schellekens, F. G. A. Versteegh, Peter F. M. Teunis · 2013 · Vaccine
68. Mumps vaccine
    Steven A. Rubin, Stanley Alan Plotkin · 2013 · Elsevier eBooks
69. Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells
    D. Neumeier, A. Yermanos, Andreas Agrafiotis, Lucia Csepregi, Tasnia Chowdhury, Roy A. Ehling, Raphael Kuhn, Tudor-Stefan Cotet, Raphaël Brisset-Di Roberto, Mariangela Di Tacchio et al. · 2021 · bioRxiv
70. SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow
    Axel Ronald Schulz, Leonard Fiebig, Heike Hirseland, Lisa‐Marie Diekmann, Simon Reinke, Sebastian Hardt, Antonia Niedobitek, Henrik E. Mei · 2023 · EBioMedicine
71. Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts
    Nathaniel Dane Lambert, Iana H. Haralambieva, Inna G. Ovsyannikova, Beth R. Larrabee, V. Shane Pankratz, Gregory A. Poland · 2013 · Immunologic Research
72. Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory
    Rachel M. Stenger, Mieke Smits, Betsy Kuipers, Jacqueline A. M. van Gaans-van den Brink, Martien C. M. Poelen, Claire J. P. Boog, Cécile A. C. M. van Els · 2010 · Vaccine
73. High throughput cellular screens to interrogate the human T and B cell repertoires
    Davide Corti, Federica Sallusto, Antonio Lanzavecchia · 2011 · Current Opinion in Immunology
74. Simultaneous Assessment of Rotavirus-Specific Memory B Cells and Serological Memory after B Cell Depletion Therapy with Rituximab
    Daniel Herrera, Olga L. Rojas, Carolina Duarte-Rey, Rubén D. Mantilla, Juana Ángel, Manuel Antonio Franco · 2014 · PLoS ONE
75. Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology
    Preethi Eldi, Tamara H. Cooper, Liang Liu, Natalie A. Prow, Kerrilyn R. Diener, Paul M. Howley, Andreas Suhrbier, John D. Hayball · 2017 · Molecular Therapy
76. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age
    Iana H. Haralambieva, Inna G. Ovsyannikova, Richard B. Kennedy, Krista M. Goergen, Diane E. Grill, Min‐hsin Chen, Lijuan Hao, Joseph P. Icenogle, Gregory A. Poland · 2019 · Vaccine
77. Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
    Seyede Atefe Hosseini, Fatemeh Zahedipour, Hamed Mirzaei, Reza Kazemi Oskuee · 2021 · International Immunopharmacology
78. H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix® vaccination
    Aditya Ambati, Davide Valentini, Emanuele Montomoli, Guilia Lapini, Fabrizio Biuso, Holger Wenschuh, Isabelle Magalhaes, Markus J. Maeurer · 2015 · Immunology
79. Measles seroprevalence among healthcare workers in South Korea during the post-elimination period
    Seung Beom Han, Sun Hee Park, Yunmi Yi, Seul Ki Ji, So Hee Jang, Min Hee Park, Ji Eun Lee, Hye Sook Jeong, Soyoung Shin · 2021 · Human Vaccines & Immunotherapeutics
80. Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans
    Alice Cho, Frauke Muecksch, Zijun Wang, Tarek Ben Tanfous, Justin DaSilva, Raphael Raspe, Brianna Johnson, Eva Bednarski, Víctor Ramos, Dennis J. Schaefer-Babajew et al. · 2022 · The Journal of Experimental Medicine
81. Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C
    Akira Nishio, Sharika Hasan, Heiyoung Park, Nana Park, Jordan H. Salas, Eduardo Salinas, Lela Kardava, Paul L. Juneau, Nicole Frumento, Guido Massaccesi et al. · 2022 · Nature Communications
82. Orthopoxvirus Seroprevalence and Infection Susceptibility in France, Bolivia, Laos, and Mali
    Léa Lucıanı, Nathanaël Lapidus, Abdennour Amroun, Alessandra Falchi, Chanthala Souksakhone, Mayfong Mayxay, Audrey Dubot‐Pérès, Paola Mariela Saba Villarroel, Issa Diarra, Ousmane Koita et al. · 2022 · Emerging infectious diseases
83. Rational design of a booster vaccine against COVID-19 based on antigenic distance
    Ye‐Fan Hu, Terrence Tsz‐Tai Yuen, Hua-Rui Gong, Bingjie Hu, Jingchu Hu, Xuansheng Lin, Rong Li, Coco Luyao Zhou, Lin‐Lei Chen, Xiaolei Wang et al. · 2023 · Cell Host & Microbe
84. Generating prophylactic immunity against arboviruses in vertebrates and invertebrates
    Daniel J. Rawle, Leon E. Hugo, Abigail L. Cox, Gregor J. Devine, Andreas Suhrbier · 2024 · Nature reviews. Immunology
85. Heparin-induced thrombocytopenia: further evidence for a unique immune response
    Christian Pötschke, Sixten Selleng, Barbara M. Bröker, Andreas Greinacher · 2012 · Blood
86. Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350
    Hoyin Mok · 2012 · The Open Virology Journal
87. Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-α therapy in children with rheumatic diseases: A cross-sectional study
    Hanna M. Ingelman-Sundberg, Åsa Laestadius, Cecilia Chrapkowska, Karina Mördrup, Bo Magnusson, Erik Sundberg, Anna Nilsson · 2016 · Vaccine
88. Measles elimination and immunisation: national surveillance trends in Japan, 2008–2015
    Shinako Inaida, S. MATSUNO, Fumio Kobune · 2017 · Epidemiology and Infection
89. The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa
    Derek J. Royer, Meghan M. Carr, Hem R. Gurung, William P. Halford, Daniel J.J. Carr · 2017 · The Journal of Immunology
90. Vaccine Development for Varicella-Zoster Virus
    Tomohiko Sadaoka, Yasuko Mori · 2018 · Advances in experimental medicine and biology
91. Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand
    Luis A. Sánchez-Vargas, Sonia Kounlavouth, Madison L. Smith, Kathryn B. Anderson, Anon Srikiatkhachorn, Damon W. Ellison, Jeffrey R. Currier, Timothy P. Endy, Anuja Mathew, Alan L. Rothman · 2019 · Frontiers in Immunology
92. Applying bioinformatics for antibody epitope prediction using affinity-selected mimotopes – relevance for vaccine design
    Galina F. Denisova, Dimitri A. Denisov, Jonathan L. Bramson · 2010 · Immunome Research
93. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis
    R. Kohlmann, Anke Salmen, Andrew Chan, Cornelius Knabbe, Jürgen Diekmann, Norbert Hermann Brockmeyer, Adriane Skaletz‐Rorowski, Claudia Michalik, Ralf Gold, Klaus Überla · 2015 · Multiple Sclerosis Journal
94. Design and Optimization of a Monkeypox virus Specific Serological Assay
    Taha Y. Taha, Michael B. Townsend, Jan Pohl, Kevin L. Karem, Inger K. Damon, Placide Mbala Kingebeni, Jean‐Jacques Muyembe Tamfum, James W. Martin, Phillip R. Pittman, John W. Huggins et al. · 2023 · Pathogens
95. SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
    Shikha Shrivastava, Joshua M. Carmen, Zhongyan Lu, Shraddha Basu, Rajeshwer Singh Sankhala, Wei‐Hung Chen, Phuong Nguyen, William C. Chang, Jocelyn King, Courtney Corbitt et al. · 2023 · npj Vaccines
96. The origins and longevity of IgE responses as indicated by serological and cellular studies in mice and humans
    Zhoujie Ding, Jesse Mulder, Marcus J Robinson · 2023 · Allergy
97. Serostatus following live attenuated vaccination administered before pediatric liver transplantation
    Takanori Funaki, Kensuke Shoji, Ippei Miyata, Seisuke Sakamoto, Mureo Kasahara, Hironori Yoshii, Isao Miyairi, Akihiko Saitoh · 2015 · Liver Transplantation
98. Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation
    Paola Martinez-Murillo, Christopher Sundling, Sijy J. O'Dell, John R. Mascola, Richard T. Wyatt, Gunilla B. Karlsson Hedestam · 2015 · Scientific Reports
99. Vaccine-Induced Protection against Orthopoxvirus Infection Is Mediated through the Combined Functions of CD4 T Cell-Dependent Antibody and CD8 T Cell Responses
    Geeta Chaudhri, Vikas Tahiliani, Preethi Eldi, Gunasegaran Karupiah · 2014 · Journal of Virology
100. Standardization of rubella immunoassays
     Christelle Vauloup‐Fellous · 2018 · Journal of Clinical Virology